Join the Leukemia group to help and get support from people like you.
Leukemia News (Page 2)
Related terms: Cancer, Leukemia
Risk for Cancer Increased for Relatives of Patients With Leukemia
THURSDAY, Jan. 18, 2024 – Relatives of patients with myelodysplastic neoplasia (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) have an increased risk for cancer, according...
Allogeneic HCT After Primary Induction Failure Beneficial in Leukemia
THURSDAY, Dec. 21, 2023 – For patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term...
American Society of Hematology, Dec. 9 to 12
The annual meeting of the American Society of Hematology was held from Dec. 9 to 12 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical...
Poor Physical Function Persists in Childhood Cancer Survivors
MONDAY, Nov. 20, 2023 – Despite changes in therapy, the prevalence of poor physical function has remained steady among childhood survivors of acute lymphoblastic leukemia (ALL) and non-Hodgkin...
Cancer Is More Lethal For Black and Hispanic Children: Report
THURSDAY, Nov. 16, 2023 (Healthday News) – While childhood cancer is no longer terminal for many, death rates remain higher in Black and Hispanic children, a new government report reveals....
Major Study Confirms CT Scans' Link to Blood Cancer Risk in Kids
FRIDAY, Nov. 10, 2023 – CT scans are significantly linked to an increased risk of blood cancers in young people, a major multinational study has found. Analysis of data from nearly 1 million people...
Children With Down Syndrome More Vulnerable to Leukemia
WEDNESDAY, Nov. 1, 2023 – While new treatments for leukemia have improved outcomes for many patients, children with Down syndrome have not benefited as much. These young people are at increased risk...
Study Looks at Palliative Care Use in Adolescents, Young Adults With Cancer
FRIDAY, Oct. 20, 2023 – For adolescents and young adults (AYA) with cancer, the likelihood of receiving specialty palliative care (SPC) is increased for those reporting moderate or severe symptoms,...
Bariatric Surgery Linked to Reduced Incidence of Hematologic Cancer
WEDNESDAY, Sept. 27, 2023 – Bariatric surgery is associated with reduced incidence of hematological cancer, especially for women, according to a study published online Sept. 13 in The Lancet Healthy...
Weight-Loss Surgery Could Lower Odds for Blood Cancers
MONDAY, Sept. 25, 2023 – Weight-loss surgery can deliver a host of health benefits, but new research reveals an unexpected one: Getting the surgery was associated with a 40% lower risk of blood...
Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
THURSDAY, Aug. 17, 2023 – Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been...
FDA Medwatch Alert: Drug Safety Communication: Copiktra (duvelisib) - FDA Warns about Possible Increased Risk of Death and Serious Side Effects
ISSUE: The FDA is warning that results from a clinical trial show a possible increased risk of death with Copiktra (duvelisib) compared to another medicine to treat a chronic blood cancer called...
FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia
21 November 2019 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patients with chronic lymphocytic leukemia (CLL) or s...
Agios Announces FDA Approval of Tibsovo as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) – Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the U.S. Food...
FDA Approves Asparlas (calaspargase pegol-mknl) for Acute Lymphoblastic Leukemia (ALL)
On December 20, 2018, the Food and Drug Administration approved calaspargase pegol-mknl (Asparlas, Servier Pharmaceuticals LLC), an asparagine specific enzyme, as a component of a multi-agent...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hairy Cell Leukemia, Blood Disorders